| Line Item | 2026-03-31 | Y/Y |
|---|---|---|
| Revenue | $1.19B | +23.9% |
| Cost of Revenue | $834.0M | +30.9% |
| Gross Profit | $359.4M | +10.4% |
| R&D Expense | $21.4M | -10.3% |
| SG&A Expense | $178.3M | +66.3% |
| Operating Income | -$119.3M | -318.7% |
| Interest Expense | $61.1M | +88.6% |
| Pre-tax Income | -$206.5M | -3651.3% |
| Income Tax | $22.9M |
| Line Item | 2026-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $96.6M | +79.9% |
| Accounts Receivable | $380.2M | +129.8% |
| Inventory | $609.0M | +206.7% |
| Current Assets | $1.18B | +153.5% |
| Total Assets | $4.78B | +175.2% |
| Current Liabilities | $584.3M | +126.6% |
| Long-term Debt | $2.38B | +419.2% |
| Line Item | 2026-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$146.2M | -420.6% |
| Capital Expenditures | $17.9M | -16.6% |
| Investing Cash Flow | -$2.46B | — |
| Financing Cash Flow | $2.65B | +3158.8% |
| Free Cash Flow | -$164.1M | -777.9% |
| +6348.0% |
| Net Income | -$229.5M | -4367.4% |
| EPS (Basic) | -$7.40 | -4011.1% |
| EPS (Diluted) | -$7.40 | -4011.1% |
| Total Liabilities |
| $3.34B |
| +289.4% |
| Stockholders' Equity | $1.45B | +64.2% |